Picture of Eurofins Scientific SE logo

ERF — Eurofins Scientific SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Berenberg cuts Eurofins to 'hold' as growth headwinds persist

** Berenberg downgrades French testing company Eurofins
Scientific  ERF.PA  to "hold" from "buy", citing disappointing
growth dynamics and lack of near-term catalysts for the stock
** The broker cuts its PT by 29% to EUR 53, vs EUR 46.08 as of
Tuesday's close
** It says top-line growth remains under pressure, particularly
in the soft pharmaceuticals market, and expects this weakness to
persist into H1 2025
** This leads to concerns over the company's ability to achieve
its mid-term organic growth target of 6.5%, it adds
** "While we see potential for EBITDA margin improvement and
free cash flow upside in FY25, we think better equity stories
exist elsewhere," the broker says
** Out of 16 analysts that cover Eurofins, five rate the stock
"strong buy" or "buy",​ seven "hold" and four​ "strong sell" or
"sell"

 (Reporting by Johan Bodinier in Gdansk)
 ((johangeorgesroger.bodinier@thomsonreuters.com))

Recent news on Eurofins Scientific SE

See all news